ReviewWorld journal of pediatrics : WJP2025

Expert consensus on the burden of respiratory syncytial virus disease and the utility of nirsevimab for disease prevention and protection of infants.

Daniel Y T Goh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.